Back
Status filter :


RESET SEARCH AND FILTERS
Immune system
Immune system / Immune system disorders and transplantation
  anakinra Non-formulary at HHFT and not suitable for primary care prescribing NICE TA685
  Solution for injection
Kineret (Swedish Orphan Biovitrum Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  antithymocyte immunoglobulin (rabbit) Non-formulary at HHFT and not suitable for primary care prescribing NICE TA481
  Solution for infusion
Antithymocyte immunoglobulin (rabbit) (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
  Powder and solvent for solution for infusion
Thymoglobulin (Sanofi) Non-formulary at HHFT and not suitable for primary care prescribing
  avacopan Non-formulary at HHFT and not suitable for primary care prescribing NICE TA825
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Oral capsule
Tavneos (Vifor Fresenius Medical Care Renal Pharma UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  azathioprine Non-formulary at HHFT and not suitable for primary care prescribing
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  basiliximab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA481
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Powder and solvent for solution for injection
Simulect (Novartis Pharmaceuticals UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  belatacept Non-formulary at HHFT and not suitable for primary care prescribing NICE TA481
  belimumab Hospital only NICE TA752
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  canakinumab Not approved for prescribing
  chloroquine Hospital only
Prescribing of chloroquine for travelling purposes

Chloroquine for malaria prophylaxis should not be issued on an NHS prescription. Patients should be prescribed this on a private prescription for travelling purposes. 

  Oral solution
Malarivon (Wallace Manufacturing Chemists Ltd) Hospital only
  ciclosporin Non-formulary at HHFT and not suitable for primary care prescribing NICE TA369
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

  Oral solution
Neoral (Novartis Pharmaceuticals UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

  Solution for infusion
Sandimmun (Novartis Pharmaceuticals UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

  everolimus Non-formulary at HHFT and not suitable for primary care prescribing NICE TA421
NICE TA432
NICE TA449
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Afinitor® NICE TA498
Certican® NICE TA348
Certican® NICE TA481
  hydroxychloroquine sulfate Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  mycophenolate mofetil Shared care guideline NICE TA481
NICE TA481
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Gastro-resistant tablet
Mycophenolate mofetil (Non-proprietary) Shared care guideline
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

Myfortic (Novartis Pharmaceuticals UK Ltd) Shared care guideline
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Oral suspension
CellCept (Roche Products Ltd) Shared care guideline
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  rituximab Hospital only NICE TA308
NICE TA195
NICE TA243
NICE TA137
NICE TA193
NICE TA226
NICE TA174
NICE TA359
NICE TA561
  Solution for infusion
MabThera (Roche Products Ltd) Hospital only
Rixathon (Sandoz Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Truxima (Celltrion Healthcare UK Ltd) Hospital only
  sirolimus Non-formulary at HHFT and not suitable for primary care prescribing NICE TA481
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Oral solution
Rapamune (Pfizer Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  tacrolimus Non-formulary at HHFT and not suitable for primary care prescribing NICE TA82
NICE TA481
NICE TA481
Medicines for kidney transplant in children, young people and adults

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

  Modified-release tablet
Envarsus (Chiesi Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Modified-release capsule
Advagraf (Astellas Pharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Solution for infusion
Prograf (Astellas Pharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  voclosporin Non-formulary at HHFT and not suitable for primary care prescribing NICE TA882
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Oral capsule
Lupkynis (Otsuka Pharmaceuticals (U.K.) Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Immune system / Multiple sclerosis
  alemtuzumab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA312
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Lemtrada (Sanofi) Non-formulary at HHFT and not suitable for primary care prescribing
  cladribine Non-formulary at HHFT and not suitable for primary care prescribing NICE TA616
NICE TA1053
  dimethyl fumarate Non-formulary at HHFT and not suitable for primary care prescribing
Plaque psoriasis

The Joint Formulary Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used in accordance with the relevant NICE Technology Appraisal(s).

Multiple slerosis

The Joint Prescribing Group (JPG) agreed NOT to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). 

Skilarence® NICE TA475
Tecfidera® NICE TA320
  Gastro-resistant capsule
Tecfidera (Biogen Idec Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  fampridine Non-formulary at HHFT and not suitable for primary care prescribing
  Modified-release tablet
Fampyra (Merz Pharma UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  fingolimod Non-formulary at HHFT and not suitable for primary care prescribing NICE TA254
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  glatiramer acetate Non-formulary at HHFT and not suitable for primary care prescribing NICE TA527
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Brabio (Viatris UK Healthcare Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Copaxone (Teva UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  interferon beta Non-formulary at HHFT and not suitable for primary care prescribing NICE TA527
NICE TA527
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Avonex (Biogen Idec Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Rebif (Merck Serono Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  Powder and solvent for solution for injection
Betaferon (Bayer Plc) Non-formulary at HHFT and not suitable for primary care prescribing
  natalizumab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA127
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for infusion
Tysabri (Biogen Idec Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  ocrelizumab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA533
NICE TA585
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  ofatumumab Non-formulary at HHFT and not suitable for primary care prescribing NICE TA699
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Kesimpta Sensoready (Novartis Pharmaceuticals UK Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  ozanimod Non-formulary at HHFT and not suitable for primary care prescribing NICE TA706
NICE TA828
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Oral capsule
Zeposia (Bristol-Myers Squibb Pharmaceuticals Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  peginterferon beta-1a Non-formulary at HHFT and not suitable for primary care prescribing NICE TA624
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Plegridy (Biogen Idec Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  ponesimod Non-formulary at HHFT and not suitable for primary care prescribing NICE TA767
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  siponimod Non-formulary at HHFT and not suitable for primary care prescribing NICE TA656
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  teriflunomide Non-formulary at HHFT and not suitable for primary care prescribing NICE TA303
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Immune system / Autoimmune hepatitis
  penicillamine Hospital only